Answers are grounded in this paper and cite their sources.
This randomized trial evaluates antimicrobial and alpha-glucosidase inhibition in novel compounds, highlighting their therapeutic potential.
AIM: ) and evaluate their dual biological potential as antimicrobials and α-Glucosidase Inhibitors. MATERIALS AND METHODS: (PDB ID: 1IYL), and (PDB ID: 3AJ7) were performed using molecular docking, MD simulation, and DFT methods. RESULTS AND DISCUSSION: findings by confirming the stability of protein-ligand complexes.
No takes yet. Share an insight, caveat, or question.
Mansi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: